Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-007560

Chief Financial Officer sold 10,000 shares at an average $176.05 ($1,760,479)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 30,774 D
2021-02-01 Sale : show line 2 in the form −600 $174.18 $104,509 30,174 D
2021-02-01 Sale : show line 3 in the form −5,213 $175.53 $915,027 24,961 D
2021-02-01 Sale : show line 4 in the form −2,777 $176.51 $490,171 22,184 D
2021-02-01 Sale : show line 5 in the form −910 $177.50 $161,525 21,274 D
2021-02-01 Sale : show line 6 in the form −500 $178.49 $89,247 20,774 D
Open-market sales · 10,000 sh · avg $176.05 · $1,760,479

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-01 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 460,159 D
Loading xslF345X03/doc4.xml…